Stock Comparison

TXG vs VEEV

10X Genomics Inc and Veeva Systems Inc Class A side by side — valuation, profitability, growth and risk.

TXG

10X Genomics Inc

Healthcare

VEEV

Veeva Systems Inc Class A

Healthcare

Valuation

Market Cap

$6.56B

$40.30B

P/E (TTM)

—

43.9

Forward P/E

827.4

27.6

Price/Sales

10.6

12.1

Price/Book

8.0

5.5

EV/EBITDA

147.4

33.2

Dividend Yield

—

Profitability

Net Margin

-3.55%

28.44%

Operating Margin

-6.06%

28.68%

Return on Equity

-9.40%

13.90%

Return on Assets

-5.05%

7.30%

Growth (YoY)

Revenue Growth

-12.70%

16.30%

Earnings Growth

0.00%

14.60%

Price & Risk

Beta

2.0

0.9

52-Week High

$58.57

$306.22

52-Week Low

$11.34

$151.43

Analyst Target

$46.31

$244.14

Compare TXG and VEEV your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.